Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemokines as mediators of tumor angiogenesis and neovascularization.

Literature DB >> 21040721

Chemokines as mediators of tumor angiogenesis and neovascularization.

Ellen C Keeley¹, Borna Mehrad, Robert M Strieter.

Abstract

Chemokines are a superfamily of structurally homologous heparin-binding proteins that influence tumor growth and metastasis. Several members of the CXC and CC chemokine families are potent inducers of neovascularization, whereas a subset of the CXC chemokines are potent inhibitors. In this paper, we review the current literature regarding the role of chemokines as mediators of tumor angiogenesis and neovascularization.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：
Chemokines

Year: 2010 PMID： 21040721 PMCID： PMC3073599 DOI： 10.1016/j.yexcr.2010.10.020

Source DB: PubMed Journal: Exp Cell Res ISSN： 0014-4827 Impact factor: 3.905

76 in total

1. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.

Authors: C Perollet; Z C Han; C Savona; J P Caen; A Bikfalvi
Journal: Blood Date: 1998-05-01 Impact factor: 22.113

2. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

Authors: S Qin; J B Rottman; P Myers; N Kassam; M Weinblatt; M Loetscher; A E Koch; B Moser; C R Mackay
Journal: J Clin Invest Date: 1998-02-15 Impact factor: 14.808

Review 3. Chemokines--chemotactic cytokines that mediate inflammation.

Authors: A D Luster
Journal: N Engl J Med Date: 1998-02-12 Impact factor: 91.245

4. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Authors: M Loetscher; B Gerber; P Loetscher; S A Jones; L Piali; I Clark-Lewis; M Baggiolini; B Moser
Journal: J Exp Med Date: 1996-09-01 Impact factor: 14.307

5. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

Authors: D A Arenberg; S L Kunkel; P J Polverini; M Glass; M D Burdick; R M Strieter
Journal: J Clin Invest Date: 1996-06-15 Impact factor: 14.808

6. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.

Authors: J Yoneda; H Kuniyasu; M A Crispens; J E Price; C D Bucana; I J Fidler
Journal: J Natl Cancer Inst Date: 1998-03-18 Impact factor: 13.506

Review 7. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression.

Authors: J Luan; R Shattuck-Brandt; H Haghnegahdar; J D Owen; R Strieter; M Burdick; C Nirodi; D Beauchamp; K N Johnson; A Richmond
Journal: J Leukoc Biol Date: 1997-11 Impact factor: 4.962

8. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.

Authors: D A Arenberg; S L Kunkel; P J Polverini; S B Morris; M D Burdick; M C Glass; D T Taub; M D Iannettoni; R I Whyte; R M Strieter
Journal: J Exp Med Date: 1996-09-01 Impact factor: 14.307

9. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.

Authors: S K Gupta; J P Singh
Journal: J Cell Biol Date: 1994-11 Impact factor: 10.539

10. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.

Authors: D R Smith; P J Polverini; S L Kunkel; M B Orringer; R I Whyte; M D Burdick; C A Wilke; R M Strieter
Journal: J Exp Med Date: 1994-05-01 Impact factor: 14.307

55 in total

1. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.

Authors: Daqing Shen; Xianxiang Cao
Journal: Int J Clin Exp Pathol Date: 2015-07-01

2. Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools.

Authors: Nese Unver
Journal: Med Oncol Date: 2021-05-13 Impact factor: 3.064

3. Association between preeclampsia and the CXC chemokine family (Review).

Authors: Xijing Liu; L I Dai; Rong Zhou
Journal: Exp Ther Med Date: 2015-03-09 Impact factor: 2.447

4. Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Authors: Je-Hung Kuo; Ya-Ping Chen; Jai-Shin Liu; Alexandre Dubrac; Cathy Quemener; Hervé Prats; Andreas Bikfalvi; Wen-guey Wu; Shih-Che Sue
Journal: J Biol Chem Date: 2013-03-27 Impact factor: 5.157

5. CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.

Authors: Oksana Kowalczuk; Tomasz Burzykowski; Wieslawa Ewa Niklinska; Miroslaw Kozlowski; Lech Chyczewski; Jacek Niklinski
Journal: Tumour Biol Date: 2014-02-06

6. High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma.

Authors: Ping Sui; Pingping Hu; Tiehong Zhang; Xiangwei Zhang; Qi Liu; Jiajun Du
Journal: Med Oncol Date: 2013-12-17 Impact factor: 3.064

7. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.

Authors: Vincent Vanheule; Rik Janssens; Daiane Boff; Nikola Kitic; Nele Berghmans; Isabelle Ronsse; Andreas J Kungl; Flavio Almeida Amaral; Mauro Martins Teixeira; Jo Van Damme; Paul Proost; Anneleen Mortier
Journal: J Biol Chem Date: 2015-07-16 Impact factor: 5.157